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Newborn screening (NBS) has high‐stakes health implications and requires rapid and
effective communication between many people and organizations. Multiple NBS stake-
holders worked together to create national guidance for reporting NBS results with HL7
(Health Level 7) messages that contain LOINC (Logical Observation Identiﬁers Names and
Codes) and SNOMED-CT (Systematized Nomenclature of Medicine–Clinical Terms) codes,
report quantitative test results, and use standardized computer‐readable UCUM units of
measure. This guidance (a LOINC panel and an example annotated HL7 message) enables
standard HL7 v2.5.1 laboratory messages to carry the information required for reporting
NBS results. Other efforts include HL7 implementation guides for reporting point-of-care
(POC) NBS results as well as standardizing follow-up of patients diagnosed with conditions
identiﬁed through NBS. If the guidance is used nationally, regional and national registries
can aggregate results from state programs to facilitate research and quality assurance and
help ensure continuity of operations following a disaster situation.
Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Newborn screening (NBS) is a complex system of public
health laboratories and follow-up programs, hospitals, clini-
cians, courier services, and families with newborns. The
information ﬂow and communication network involved in
NBS combined with the growing adoption of electronic health3
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v (R.M. Goodwin).records (EHRs) and electronic exchange of laboratory test
results, created an opportunity to develop consensus‐based
standard vocabularies that would enable NBS health infor-
mation exchange (HIE) as well as provide a foundation for
establishing research and quality measures.1–3 In 2009,
Downing et al.3 described the potential beneﬁts of using
health information technology (HIT) for NBS and the initialder the CC BY-NC-ND license
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update, we summarize the efforts over the last 5 years to
make HIT use for NBS a reality.Background
Members of multiple government agencies, NBS programs,
and laboratories worked together to develop standardized
guidance for electronic reporting of NBS results4 using
nationally accepted vocabulary5,6 and electronic messaging
standards: (1) LOINC (Logical Observation Identiﬁers Names
and Codes) contains standard codes for identifying laboratory
tests and other clinical measures; (2) SNOMED CT (Systemat-
ized Nomenclature of Medicine—Clinical Terms) is an inter-
national terminology standard for systematically specifying
symptoms and diagnoses; (3) UCUM (Uniﬁed Code for Units of
Measure) speciﬁes the units for a given test or measure in a
standard, machine‐readable format; and (4) HL7 (Health Level
7) speciﬁes the standards for electronic messaging. The
guidance includes a comprehensive LOINC panel and an
example annotated HL7 message that states can use as a
template to develop their speciﬁcations for transmitting
electronic NBS result messages.7 The National Library of
Medicine (NLM) has continued to reﬁne and add to this
guidance, as new conditions are added to NBS.
Other efforts in the area of NBS HIT include publication of
implementation guides for NBS dried blood spot (DBS) orders8
and results9 reporting and balloting of HL7 implementation
guides for point-of-care (POC) critical congenital heart disease
(CCHD)10 and infant hearing11 screening. A 2013 survey
conducted by the Association of Public Health Laboratories
(APHL), which is described in more detail below, assessed
different state NBS programs’ progress in implementing HIT
systems for NBS. This HIT work is also evolving beyond NBS,
to short- and long-term follow-up, because the infant NBS is
only the ﬁrst step in a long continuum of care.HRSA/NLM HIT guidance for NBS
In 2009, the NLM and the Health Resources and Services
Administration (HRSA) created a LOINC panel that covered all
of the conditions stated on the Secretary of Health and
Human Services’ Advisory Committee on Heritable Disorders
in Newborns and Children’s (SACHDNC) Recommended Uni-
form Screening Panel (RUSP)12 as well as other conditions
that were screened by any U.S. NBS program.13 It included
amino acid, acylcarnitine, endocrine, and hemoglobin disor-
ders, as well as infant hearing screening. The NLM/HRSA
guidance also included an example HL7 NBS result message
with detailed annotations that was meant to be a primer on
electronic messaging and data standards. The NLM worked
closely with several state NBS programs, reviewed their early
test HL7 messages, and reﬁned the LOINC panel and HL7
messaging guidance based on their feedback. This work
was reviewed by the SACHDNC Laboratory Standards and
Procedures Subcommittee and ﬁrst published on the NLM
NBS website (http://newbornscreeningcodes.nlm.nih.gov) in
September 2009.The messaging guidance included help for transitioning
from local codes to standard codes or, for the systems that
need to continue using local codes, for incorporating both
into their HL7 messages. For example, the HL7 message can
include both the standard LOINC code and test name (in
italics for illustrative purposes) and the local code and test
name (underlined, also for illustrative purposes) for the third
ﬁeld (observation ID) of the observation (OBX) segment:
OBX|4|NM|59407-7^Oxygen saturation in Blood Preductal by
Pulse oximetry^LN^Pre-SaO2^Preductal O2 saturation^L||
99|%|495|N|||F
The ﬁfth ﬁeld of the OBX segment can carry both a standard
SNOMED CT code and name (in italics) and either a LOINC
answer (LA) code and name or a local code and name
(underlined) for the NBS condition:
OBX|4|CE|57131-5^Newborn conditions with positive
markers [Identifier] in Dried blood spot^LN|1|
128596003^Medium-chain acyl-coenzyme A dehydrogenase
deﬁciency^SCT^ MCAD^Med-chain acyl-coenzyme A dehydro
def^L|||A|||F
Since the original LOINC panel and HL7 example message
were published, NLM has been continuously reﬁning the
guidance based on feedback from NBS programs and other
stakeholders. As an example, the original LOINC panel
included a method for reporting hemoglobin screening
results that was based on hemoglobin patterns, which was
unsustainable, as the number of hemoglobin variants that
states could identify continued to grow. The NLM worked
with hemoglobin and NBS experts from multiple federal and
state agencies and NBS programs to devise a new method for
reporting hemoglobin screening results based on reporting
the individual hemoglobin variants suspected rather than the
pattern or peaks observed. The NLM and the Regenstrief
Institute created a LOINC panel containing ﬁve LOINC codes
for reporting up to ﬁve suspected hemoglobins in a specimen
in terms of their relative concentrations (Table 1). Depending
on the number of hemoglobins suspected in a given sample,
one to all the ﬁve codes can be used in separate HL7 message
segments. For example, the following three HL7 OBX seg-
ments together represent the three hemoglobin types sus-
pected (F, A, and S) in the order of decreasing concentration
in a single NBS specimen:
OBX|1|CE|64117-5^ Most predominant hemoglobin
^LN^^^ |1| LA16208-3^Hb F^LN ||||||F||| 2009071414
5203
OBX|2|CE|64118-3^Second most predominant
hemoglobin^LN^^^ |1|LA11112-2^Hb A^LN ||||||F|||
20090714145203
OBX|3|CE|64119-1^Third most predominant
hemoglobin ^LN^^^ |1| LA13007-2^Hb S^LN ||||||F|||
20090714145203
The new method is easy to understand and complies with
HL7 messaging standards, while remaining straightforward
to implement using LOINC codes.
In May 2011, the SACHDNC Laboratory Standards and
Procedures Subcommittee suggested that the NLM review
Table 1 – LOINC panel 64116-7 for NBS suspected hemo-
globin observations.
LOINC observation long common name LOINC
code
Hemoglobin observations newborn screening panel 64116-7
Most predominant hemoglobin in dried blood spot 64117-5
Second most predominant hemoglobin in dried
blood spot
64118-3
Third most predominant hemoglobin in dried blood
spot
64119-1
Fourth most predominant hemoglobin in dried
blood spot
64120-9
Fifth most predominant hemoglobin in dried blood
spot
64121-7
Hemoglobins that can be presumptively identiﬁed
based on available controls in dried blood spot
64122-5
Panel of LOINC codes for reporting up to ﬁve hemoglobin types
suspected to be present in a NBS dried blood spot sample.
Table 2 – LOINC panel 73805-4 for newborn critical
congenital heart disease (CCHD) screening.
LOINC observation long common name LOINC
code
UCUM
units
CCHD newborn screening panel 73805-4
CCHD newborn screening interpretation 73700-7
Oxygen saturation.preductal-oxygen
saturation.postductal (mass fraction
difference) in
Bld. preductal and Bld.postductal
73696-7 %
Newborn age in hours 73806-2 h
Number of prior CCHD screens (#)
Qualitative
73699-1
Oxygen saturation sensor name 73804-7
Oxygen saturation sensor type 73803-9
Oxygen saturation sensor wrap name 73802-1
Oxygen saturation sensor wrap type 73801-3
Oxygen saturation sensor wrap size 73800-5
CCHD newborn screening protocol used
(type)
73697-5
Reason CCHD oxygen saturation 73698-3
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screening interpretation.” The NLM reviewed the “clinical
events” answer list with representatives from NBS programs
and the APHL Newborn Screening and Genetics in Public
Health Committee. They also conducted an evidence‐based
literature search to develop a proposal for revising it14–16 and
reached consensus for a revised set of LOINC codes and
answer lists. Based on the ﬁndings, the NLM split the “Clinical
events that affect newborn screening interpretation” into
three separate LOINC observations: “Infant NICU Factors that
Affect Newborn Screening Interpretation,” “Maternal Factors
that Affect Newborn Screening Interpretation,” and “Feeding
Types.” Based on the infant’s history, clinicians can select
one or more responses from the answer list for each question.
Each of these three LOINC codes with answer lists includes a
deﬁnition/description, explaining which NBS assays are
affected by particular feeding types, infant NICU, or maternal
factors. Each of the three questions also offers an answer
option “Other,” if selected, narrative (Nar) data type LOINC
codes are available to provide details.screening not performed
Oxygen saturation in blood preductal by
pulse oximetry
59407-7 %
Heart rate blood preductal pulse oximetry 73799-9 /min
Perfusion index blood preductal pulse
oximetry
73798-1 %
Signal-quality blood preductal pulse
oximetry
73797-3
Infant activity during preductal oxygen
saturation measurement
73796-5
Oxygen saturation in blood postductal by
pulse oximetry
59418-4 %
Heart rate blood postductal pulse
oximetry
73795-7 /min
Perfusion index blood postductal pulse
oximetry
73794-0 %
Signal-quality blood postductal pulse
oximetry
73793-2
Infant activity during postductal oxygen
saturation measurement
73792-4
Panel of LOINC codes to report newborn CCHD screening results
and associated information.New additions to NBS LOINC panel
As new conditions and methods have been added to NBS over
the years, both the LOINC panel and the example HL7
message, which are adaptable, have been updated accord-
ingly. When severe combined immunodeﬁciency (SCID) was
added to the RUSP by the SACHDNC in May 2010, the NLM
developed new condition and analyte variables for this
condition. The SCID panel (LOINC code 62333‐0) includes
codes for the quantitative T-cell receptor excision circle
(TREC) assay, test interpretation, and comment/discussion.
Additional variables and codes can be added following addi-
tion of a new condition to the RUSP.
Critical congenital heart disease (CCHD) was added to the
RUSP in 2011 as a second POC screening, joining early hearing
loss. Many variables are captured and reported, and out-of-
range results require immediate follow-up. While there are
variations on CCHD screening protocols, most begin byconsidering a preductal and postductal oxygen saturation
measurement and the difference between the two. Abnormal
screens may be followed by diagnostic testing or subsequent
measurements at speciﬁed intervals depending upon the
initial result. To accommodate the intricacies of point-of-care
screening for CCHD, the LOINC panel (code 73805-4) includes
terms for the actual screening results (preductal and post-
ductal oxygen saturation measurements), several variables
that are related to the screening process (e.g., type of sensor
and sensor wrap), and related physiologic measurements such
as heart rate (Table 2). Each program can use the appropriate
combination of the available CCHD codes to reﬂect its protocol.
Several NBS programs have started pilot studies or imple-
mented screening for ﬁve of the lysosomal storage disorders
(LSDs): Fabry disease, Pompe disease, Gaucher disease, Nie-
mann–Pick disease A/B, and Krabbe disease. A workgroup of
LSD experts analyzed variations in naming LSDs and the tests
used for screening as part of a larger evidence review and
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agement of the presymptomatic LSD patient.17 Informed by
this work, the NLM and the HRSA collaborated with the
workgroup plus other LSD and NBS experts, selected standard
names, assigned standard LOINC and SNOMED CT codes to
LSD tests and conditions, and updated the example electronic
HL7 message to illustrate how to use these codes to report
NBS LSD results.
The NLM and the Regenstrief Institute also worked with
Oregon’s NBS program to develop new LOINC codes for
analytes measured using the non‐derivatized tandem mass
spectrometry (MS/MS) test kit method. The methods for
derivatized and non‐derivatized MS/MS are similar and
nearly all reports of analyte values and ratios will be identi-
cal; however, by consulting with experts, we identiﬁed
exceptions for which we obtained new LOINC codes.HL7 messaging guides
In 2011, the Public Health Informatics Institute (PHII), funded
by a HRSA grant, published implementation guides for NBS
dried blood spot (DBS) orders8 and results9 based on HL7
messaging. PHII worked with representatives from public
health laboratories, public health agencies, and NLM. NewS-
TEPs (Newborn Screening Technical assistance and Evalua-
tion program), a HRSA-funded cooperative agreement that is
a collaboration between APHL and the Colorado School of
Public Health, is building on the PHII work by ﬁnalizing the
HL7 implementation guide for NBS DBS results and submit-
ting it for formal HL7 balloting.
In 2012, implementation guides for reporting CCHD and
EHDI results were balloted through HL7. The NLM helped
align the HL7 guides with the existing LOINC codes and
updated the existing codes as necessary. In conjunction with
this work, the NLM revised the NBS LOINC panel to create a
separate subpanel for POC results.State progress in implementing HIT for NBS
The NLM has worked closely with several state NBS programs
to help map their local codes to LOINC and review their
preliminary HL7 messages. At least 15 states are mapping to
standard LOINC and SNOMED CT codes and building infra-
structure to exchange NBS orders and results with hospitals
and providers, public health, or health information
exchanges (HIEs) via HL7 messages based on the HRSA/NLM
guidance. To further enrich and better utilize the NBS data,
several states are working to integrate their NBS systems
with related systems, including long-term follow-up, vital
records (birth certiﬁcates), and immunization registries.
“Please contact the corresponding author for more informa-
tion if you have questions about speciﬁc state NBS programs.”
APHL conducted a survey of U.S. NBS programs in 2013, in
order to understand the current landscape of health HIT
implementation for NBS. One representative from each NBS
program in the country received the survey electronically,
with respondents encouraged to seek information from other
individuals (including HIT personnel) when completing thesurvey. Survey participation was voluntary. In accordance
with APHL’s Data Access and Sharing policy, the reports and
ﬁndings related to this survey were released only in aggregate
data form without individual identiﬁers.18 Overall, 33 NBS
programs participated in the survey; however, some answers
were completed by a subset of the total. Internal data
integration between laboratory and follow-up programs was
reported in 27/32 programs, with 23/27 reported to be fully
automated internal data sharing. Data exchange with entities
outside the NBS program was reported by 15/32 (47%) of the
programs. The programs exchange NBS data with birthing
hospitals (n ¼ 9), physician ofﬁces (n ¼ 6), vital records (n ¼ 7),
immunization registries (n ¼ 1), early hearing detection
intervention data systems (n ¼ 6), CCHD data systems (n ¼
1), and birth defects registries (n ¼ 11). Of programs exchang-
ing data, the most common type of information exchanged
was NBS results, exchanged in 13 programs (HL7 ¼ 10
programs, CSV ﬁle ¼ 3 programs), while NBS orders are
exchanged by 6 programs (HL7 ¼ 6/6 programs).
Further, NBS screening program data sharing happens
through web portals where users can access NBS results
through a secure website (13/30, 43%), allowing access to
NBS results to authorized users 24 hours a day. In addition to
results on individual newborns, program performance met-
rics are available through web portals in some programs,
reporting information such as the timing of specimen receipt
by lab and subsequent result turnaround time (n ¼ 5), number
of rejected samples due to inadequate collection (n ¼ 7), and
other ad hoc reports that are unique to an individual program
(n ¼ 3). The web portals can be accessed by physicians,
midwives, hospitals, and other state NBS programs when
services are shared through regional laboratories.
The biggest challenges for state NBS programs in imple-
menting NBS HIT were competing priorities (22/33, 67%), lack
of HIT expertise (14/33, 42%), and lack of funding (14/33, 42%).Beyond NBS
Because NBS is only a ﬁrst step in a longer continuum of care,
the NLM’s collaboration with NBS programs has also con-
tributed to the development of other codes such as diet
monitoring codes for children with phenylketonuria (PKU)
and other conditions diagnosed after NBS. This work began
with a request from the Oregon NBS program for certain
codes because the Oregon NBS lab processes samples from
patients with metabolic disorders in Alaska whose parents
periodically draw DBS samples at home and send to Oregon
for processing. The NLM gathered information from state as
well as international NBS programs on the full scope of
conditions monitored by DBS and the analytes used for
monitoring and worked with Regenstrief Institute to create
a LOINC panel with codes for dietary monitoring of condi-
tions diagnosed on NBS (Table 3).Discussion
NBS is on the forefront of public health adoption of health
information technology. Using standard codes and names will
Table 3 – LOINC panel 74874-9 for monitoring metabolic disorders using dried blood spots (DBS).
LOINC observation long common name LOINC code UCUM units
Metabolic disorder therapy monitoring panel—dried blood spot 74874-9
Sample quality of dried blood spot 57718-9
Reason for unsatisfactory specimen not related to sample quality of dried blood spot 74482-1
Metabolic disorder being monitored (Identiﬁer) in dried blood spot 74873-1
Alloisoleucine (moles/volume) in dried blood spot—posttherapeutic diet 74875-6 mmol/L
Arginine (moles/volume) in dried blood spot—posttherapeutic diet 74876-4 mmol/L
Argininosuccinate (moles/volume) in dried blood spot—posttherapeutic diet 74877-2 mmol/L
Carnitine free (C0) (moles/volume) in dried blood spot—posttherapeutic diet 74878-0 mmol/L
Galactose (mass/volume) in dried blood spot—posttherapeutic diet 75093-5 mg/dL
Galactose 1 phosphate (mass/volume) in dried blood spot—posttherapeutic diet 74879-8 mg/dL
Galactose 1 phosphate uridyl transferase (enzymatic activity/volume) in dried blood
spot—posttherapeutic diet
75094-3 U/g (Hb)
Hydroxyproline (moles/volume) in dried blood spot—posttherapeutic diet 74880-6 mmol/L
Isoleucine (moles/volume) in dried blood spot—posttherapeutic diet 74881-4 mmol/L
Leucine (moles/volume) in dried blood spot—posttherapeutic diet 74882-2 mmol/L
Ornithine (moles/volume) in dried blood spot—posttherapeutic diet 74883-0 mmol/L
Phenylalanine/tyrosine (molar ratio) in dried blood spot—posttherapeutic diet 74300-5 (ratio)
Phenylalanine (moles/volume) in dried blood spot—posttherapeutic diet 74303-9 mmol/L
Succinylacetone (moles/volume) in dried blood spot—posttherapeutic diet 74301-3 mmol/L
Tyrosine/phenylalanine (molar ratio) in dried blood spot—posttherapeutic diet 74299-9 (Ratio)
Tyrosine (moles/volume) in dried blood spot—posttherapeutic diet 74302-1 mmol/L
Valine (moles/volume) in dried blood spot—posttherapeutic diet 74884-8 mmol/L
Panel of LOINC codes to report DBS monitoring results for metabolic disorders diagnosed by NBS.
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researchers to exchange and aggregate NBS results from all
of the states, which is critical for quality assurance, quality
improvement, and research to identify better methods in NBS.
Full implementation of health information exchange within
NBS will facilitate a more efﬁcient system, resulting in a more
timely turnaround for NBS results and a decreased workload in
NBS programs. While there are still some challenges ahead to
reach full implementation, there is a momentum toward
integrating data exchange capabilities in NBS programs. NBS
laboratory instrument and information systems vendors
including PerkinElmer, OZ Systems, and Natus Neometrics
have incorporated NBS LOINC codes and HL7 messaging for
NBS based on the HRSA/NLM guidance into their systems and
are working with state NBS programs to facilitate adoption of
HIT for NBS. As NBS programs adopt data exchange models
and new state-of-the art data systems, they are adapting
reporting capabilities for each hospital and provider served, a
process that is unique to each hospital and provider.
NBS programs that have legacy electronic systems or
paper‐based systems that use local codes can send both local
and standard codes in their HL7 messages as a way to
preserve backwards compatibility during the transition from
legacy local coding systems to national standard codes.
Electronic messaging allows NBS programs to send data to
multiple recipients at the same time, including the birth
hospital, post‐discharge provider and practice, metabolic
specialist, health information exchange, and state registry.
Because some states may not want to send all quantitative
results to all message recipients, they can utilize HL7 features
such as normal/abnormal ﬂags or ﬁltering on speciﬁc LOINC
codes to send speciﬁc results or types of results to the
selected categories of message recipients.The authors believe that when results are out of range or
indeterminate, laboratories should send the quantitative
results to the birth institution and attending clinicians,
particularly when ﬁxed cutoffs are used.3 Pediatric subspe-
cialists who work with state NBS programs anecdotally state
that they would prefer to have interpretations rather than
quantitative results reported to the birth hospital and pedia-
tric providers because they want to avoid misinterpretation
of results and unnecessary phone calls and referrals. How-
ever, quantitative data can be valuable for interpreting the
results and providing concrete information to the family until
the infant sees the appropriate specialist or has follow‐up
testing done. In cases where dried blood spot result ranges
differ from the usual serum results familiar to primary care
physicians, minimal educational information delivered with
the results should assist them in result interpretation. Fur-
thermore, we encourage NBS laboratories to report all quan-
titative results (not just interpretations) and appropriate
accompanying explanatory information to the NBS follow-
up programs so information can be maintained for compar-
ison over time.3
Considering that many states share a regional laboratory or
use the same laboratory information management systems
(LIMS) software, there is an opportunity for states to share
their HIT adoption methods with other programs to reduce
costs. In addition, open source MIRTH software19 and com-
mercial BizTalk software can facilitate development of mes-
saging by adapting existing functions to local needs through
use of mapping tables, and implementation protocols could
be shared between early implementers and other programs.
Further collaborations can be considered between LIMS and
large hospital systems that may share a common electronic
health record system.
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While standard codes and electronic messaging guidance are
important, NBS program resources and infrastructure for imple-
menting HIT are as important. Much progress has been made
over the last 5 years in both standards development and NBS
program implementation. We hope adoption of HIT in NBS will
continue to grow, because using standard codes and names as
well as electronic messaging has the potential to allow faster
results reporting, improve patient follow-up and continuity of
care, and facilitate aggregation of NBS results across programs.Acknowledgments
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